Cargando…
Emerging Nanomedicines for the Treatment of Atopic Dermatitis
Globally, the prevalence of Atopic dermatitis (AD) is significantly increasing and affecting around 20% of population including children. Complex interactions amongst abnormality in epidermal barrier function, environment, infectious agents and immunological defects are considered as key factors in...
Autores principales: | Parekh, Khushali, Mehta, Tejal A, Dhas, Namdev, Kumar, Pavan, Popat, Amirali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828097/ https://www.ncbi.nlm.nih.gov/pubmed/33486609 http://dx.doi.org/10.1208/s12249-021-01920-3 |
Ejemplares similares
-
Emerging Systemic Treatments for Atopic Dermatitis
por: Ferrucci, Silvia Mariel, et al.
Publicado: (2023) -
New and emerging trends in the treatment of atopic dermatitis
por: Gelbard, Christina M, et al.
Publicado: (2008) -
A Therapeutic Renaissance – Emerging Treatments for Atopic Dermatitis
por: NA, Chan Ho, et al.
Publicado: (2020) -
New and Emerging Systemic Treatments for Atopic Dermatitis
por: Newsom, Megan, et al.
Publicado: (2020) -
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Singh, Rhea, et al.
Publicado: (2020)